ADAR1 Capital Management’s Kezar Life Sciences KZR Stock Holding History

ADAR1 Capital Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-81,933	Closed	-$608K	–	315
2026 Q1	$608K	Sell	81,933 -35,507	-30%	-$231K	0.04%	194
2025 Q4	$739K	Sell	117,440 -7,527	-6%	-$43.9K	0.05%	159
2025 Q3	$487K	Sell	124,967 -22,437	-15%	-$92K	0.05%	137
2025 Q2	$675K	Hold	147,404	–	–	0.1%	102
2025 Q1	$719K	Hold	147,404	–	–	0.13%	89
2024 Q4	$991K	Buy	147,404 +13,577	+10%	+$101K	0.2%	77
2024 Q3	$1.03M	Buy	133,827 +25,177	+23%	+$152K	0.17%	74
2024 Q2	$652K	Buy	108,650 +84,988	+359%	+$646K	0.12%	85
2024 Q1	$213K	Buy	+23,662	New	+$216K	0.05%	117

ADAR1 Capital Management's KZR Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 81,933 shares — an estimated $608K sold.

ADAR1 Capital Management first reported a position in KZR in Q1 2024 and held it in 9 quarters. The position peaked at $1.03M in Q3 2024. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

ADAR1 Capital Management reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
ADAR1 Capital Management sold 81,933 Kezar Life Sciences shares in Q2 2026, an estimated $608K.
ADAR1 Capital Management first reported a position in Kezar Life Sciences in Q1 2024 and held it in 9 quarters.
ADAR1 Capital Management's Kezar Life Sciences position peaked at $1.03M in Q3 2024.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.